License Required
Descovy® Emtricitabine/Tenofovir Alafenamide 200mg/25mg HIV Treatment Tablets - 30 Count Bottle
61958200201 | USAMP#53225434
container type
dosage form
strength
Secure Checkout
Verified Supply Chain
Priority Fulfillment
Locked
Base Price
$3,775.95
BT
🎯 Unlock Your Custom Tiered Price
15-35% bulk discounts
100+
units
10% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
250+
units
20% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
500+
units
30% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
Unlock Bulk Pricing
See pricing for all volume tiers
Instant access to volume pricing. Register free to compare all tiers and calculate your exact savings.
5,000+ verified buyers
Average savings:$23,400/year
15-35% OFF
for healthcare facilities on bulk orders
24/7 Live Chat!
Instant support anytime
Product Spotlight
- Formulated for the treatment and management of HIV-1 infection in adults and pediatric patients weighing at least 25 kg.
- Film-coated tablets for easier swallowing and absorption.
- Combines two powerful antiretroviral medications, Emtricitabine and Tenofovir Alafenamide, in a single tablet.
- Manufactured by Gilead Sciences Inc, a leader in antiretroviral therapy.
- Each bottle contains a one-month supply (30 tablets) for convenient dosing.
- Designed to be part of a complete antiretroviral treatment regimen for HIV.
